Strand Life Sciences to Acquire Medical Arm of Quest Diagnostics
Bengaluru-based silico technology company Strand Life Sciences Pvt. Ltd has entered a deal to acquire the India medical diagnostics business of New York Stock Exchange-listed Quest Diagnostics Inc.
However, the financial details of the deal have not been disclosed yet. Ramesh Hariharan, CEO at Strand Life stated that the deal will add strong North India presence and marquee clientele that includes hospital chains, corporate houses and pharmaceutical companies to the company’s portfolio.
“This acquisition is an important addition to our network of 24 diagnostic labs across India, especially as we continue to expand our work in oncology, genomics, and precision medicine,” Ramesh Hariharan, CEO at Strand Life, said.
On the other hand, Quest has a 65,000-square-feet laboratory in Gurugam....